-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Next Steps for ASH Guidelines on Use of Anticoagulation in Patients with COVID-19

Program: Special-Interest Sessions
Session: ASH Guidelines on Venous Thromboembolism (VTE): What's New
Hematology Disease Topics & Pathways:
Bleeding and Clotting, Clinical Practice (Health Services and Quality), thromboembolism, Diseases, SARS-CoV-2/COVID-19, thrombotic disorders, Infectious Diseases
Monday, December 11, 2023, 4:30 PM-6:00 PM

Deborah Siegal, MD, MSc

Department of Medicine, University of Ottawa, Ottawa, ON, Canada

Disclosures: Siegal: Roche: Honoraria, Other: paid indirectly to my institution; Servier: Honoraria, Other: paid indirectly to my institution; BMS-Pfizer: Honoraria, Other: paid indirectly to my institution; Astra Zeneca: Honoraria, Other: paid indirectly to my institution.

See more of: ASH Guidelines on Venous Thromboembolism (VTE): What's New
See more of: Special-Interest Sessions
<< Previous Presentation | Next Presentation >>